Retaglutide is a innovative GLP-1 receptor agonist currently under research for the control of obesity. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://larissamghy068425.targetblogs.com/39358980/retaglutide-a-promising-glp-1-receptor-agonist